ArticleFrontiers in pharmacology2026

Prim-O-glucosylcimifugin ameliorates DSS-induced ulcerative colitis via suppressing NLRP3 inflammasome activation.

Fuqian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.